HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study.
Identifieur interne : 004191 ( Ncbi/Merge ); précédent : 004190; suivant : 004192HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study.
Auteurs : Léa Duchesne [France] ; Richard Njouom [Cameroun] ; Frédéric Lissock [Cameroun] ; Gishlaine Flore Tamko-Mella [Cameroun] ; Sandrine Rallier [France] ; Lila Poiteau [France] ; Alexandre Soulier [France] ; Stéphane Chevaliez [France] ; Guy Vernet [Cameroun] ; Nicolas Rouveau [France] ; Jean-Michel Pawlotsky [France] ; Pierre-Marie Girard [France] ; Karine Lacombe [France]Source :
- Journal of the International AIDS Society [ 1758-2652 ] ; 2017.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Anticorps de l'hépatite C (sang), Antigènes de l'hépatite C (sang), Cameroun (épidémiologie), Co-infection, Courbe ROC, Femelle, Humains, Hépatite B (), Hépatite C chronique (), Hépatite C chronique (diagnostic), Hépatite C chronique (virologie), Hépatite C chronique (épidémiologie), Infections à VIH (), Infections à VIH (épidémiologie), Mâle, Sensibilité et spécificité, Sujet âgé, Études transversales.
- MESH :
- diagnostic : Hépatite C chronique.
- sang : Anticorps de l'hépatite C, Antigènes de l'hépatite C.
- virologie : Hépatite C chronique.
- épidémiologie : Cameroun, Hépatite C chronique, Infections à VIH.
- Adulte, Adulte d'âge moyen, Co-infection, Courbe ROC, Femelle, Humains, Hépatite B, Hépatite C chronique, Infections à VIH, Mâle, Sensibilité et spécificité, Sujet âgé, Études transversales.
English descriptors
- KwdEn :
- Adult, Aged, Cameroon (epidemiology), Coinfection, Cross-Sectional Studies, Female, HIV Infections (complications), HIV Infections (epidemiology), Hepatitis B (complications), Hepatitis C Antibodies (blood), Hepatitis C Antigens (blood), Hepatitis C, Chronic (complications), Hepatitis C, Chronic (diagnosis), Hepatitis C, Chronic (epidemiology), Hepatitis C, Chronic (virology), Humans, Male, Middle Aged, ROC Curve, Sensitivity and Specificity.
- MESH :
- chemical , blood : Hepatitis C Antibodies, Hepatitis C Antigens.
- complications : HIV Infections, Hepatitis B, Hepatitis C, Chronic.
- diagnosis : Hepatitis C, Chronic.
- epidemiology : Cameroon, HIV Infections, Hepatitis C, Chronic.
- virology : Hepatitis C, Chronic.
- Adult, Aged, Coinfection, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, ROC Curve, Sensitivity and Specificity.
Abstract
The diagnostic procedure for chronic hepatitis C infection (CHC) usually combines anti-HCV antibody (HCV-Ab) and HCV-RNA measurement. Quantifying HCV core antigen (cAg) as a one-step procedure could shorten the diagnostic process. We aimed to assess the performance of cAg quantification in diagnosing CHC and how it is influenced by concomitant HIV or HBV infections.
DOI: 10.7448/IAS.20.1.21446
PubMed: 28530032
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000D33
- to stream PubMed, to step Curation: 000D33
- to stream PubMed, to step Checkpoint: 000D33
Links to Exploration step
pubmed:28530032Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study.</title><author><name sortKey="Duchesne, Lea" sort="Duchesne, Lea" uniqKey="Duchesne L" first="Léa" last="Duchesne">Léa Duchesne</name><affiliation wicri:level="3"><nlm:affiliation>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Njouom, Richard" sort="Njouom, Richard" uniqKey="Njouom R" first="Richard" last="Njouom">Richard Njouom</name><affiliation wicri:level="1"><nlm:affiliation>Virology Department, Pasteur Center of Cameroun, Yaoundé, Cameroon.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Virology Department, Pasteur Center of Cameroun, Yaoundé</wicri:regionArea><wicri:noRegion>Yaoundé</wicri:noRegion></affiliation></author><author><name sortKey="Lissock, Frederic" sort="Lissock, Frederic" uniqKey="Lissock F" first="Frédéric" last="Lissock">Frédéric Lissock</name><affiliation wicri:level="1"><nlm:affiliation>Virology Department, Pasteur Center of Cameroun, Yaoundé, Cameroon.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Virology Department, Pasteur Center of Cameroun, Yaoundé</wicri:regionArea><wicri:noRegion>Yaoundé</wicri:noRegion></affiliation></author><author><name sortKey="Tamko Mella, Gishlaine Flore" sort="Tamko Mella, Gishlaine Flore" uniqKey="Tamko Mella G" first="Gishlaine Flore" last="Tamko-Mella">Gishlaine Flore Tamko-Mella</name><affiliation wicri:level="1"><nlm:affiliation>Virology Department, Pasteur Center of Cameroun, Yaoundé, Cameroon.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Virology Department, Pasteur Center of Cameroun, Yaoundé</wicri:regionArea><wicri:noRegion>Yaoundé</wicri:noRegion></affiliation></author><author><name sortKey="Rallier, Sandrine" sort="Rallier, Sandrine" uniqKey="Rallier S" first="Sandrine" last="Rallier">Sandrine Rallier</name><affiliation wicri:level="3"><nlm:affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Créteil</settlement></placeName></affiliation></author><author><name sortKey="Poiteau, Lila" sort="Poiteau, Lila" uniqKey="Poiteau L" first="Lila" last="Poiteau">Lila Poiteau</name><affiliation wicri:level="3"><nlm:affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Créteil</settlement></placeName></affiliation></author><author><name sortKey="Soulier, Alexandre" sort="Soulier, Alexandre" uniqKey="Soulier A" first="Alexandre" last="Soulier">Alexandre Soulier</name><affiliation wicri:level="3"><nlm:affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Créteil</settlement></placeName></affiliation></author><author><name sortKey="Chevaliez, Stephane" sort="Chevaliez, Stephane" uniqKey="Chevaliez S" first="Stéphane" last="Chevaliez">Stéphane Chevaliez</name><affiliation wicri:level="3"><nlm:affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Créteil</settlement></placeName></affiliation></author><author><name sortKey="Vernet, Guy" sort="Vernet, Guy" uniqKey="Vernet G" first="Guy" last="Vernet">Guy Vernet</name><affiliation wicri:level="1"><nlm:affiliation>Virology Department, Pasteur Center of Cameroun, Yaoundé, Cameroon.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Virology Department, Pasteur Center of Cameroun, Yaoundé</wicri:regionArea><wicri:noRegion>Yaoundé</wicri:noRegion></affiliation></author><author><name sortKey="Rouveau, Nicolas" sort="Rouveau, Nicolas" uniqKey="Rouveau N" first="Nicolas" last="Rouveau">Nicolas Rouveau</name><affiliation wicri:level="3"><nlm:affiliation>"Research in Resource-Limited Settings" Department, ANRS, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>"Research in Resource-Limited Settings" Department, ANRS, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Pawlotsky, Jean Michel" sort="Pawlotsky, Jean Michel" uniqKey="Pawlotsky J" first="Jean-Michel" last="Pawlotsky">Jean-Michel Pawlotsky</name><affiliation wicri:level="3"><nlm:affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Créteil</settlement></placeName></affiliation></author><author><name sortKey="Girard, Pierre Marie" sort="Girard, Pierre Marie" uniqKey="Girard P" first="Pierre-Marie" last="Girard">Pierre-Marie Girard</name><affiliation wicri:level="3"><nlm:affiliation>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Lacombe, Karine" sort="Lacombe, Karine" uniqKey="Lacombe K" first="Karine" last="Lacombe">Karine Lacombe</name><affiliation wicri:level="3"><nlm:affiliation>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28530032</idno><idno type="pmid">28530032</idno><idno type="doi">10.7448/IAS.20.1.21446</idno><idno type="wicri:Area/PubMed/Corpus">000D33</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D33</idno><idno type="wicri:Area/PubMed/Curation">000D33</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D33</idno><idno type="wicri:Area/PubMed/Checkpoint">000D33</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000D33</idno><idno type="wicri:Area/Ncbi/Merge">004191</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study.</title><author><name sortKey="Duchesne, Lea" sort="Duchesne, Lea" uniqKey="Duchesne L" first="Léa" last="Duchesne">Léa Duchesne</name><affiliation wicri:level="3"><nlm:affiliation>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Njouom, Richard" sort="Njouom, Richard" uniqKey="Njouom R" first="Richard" last="Njouom">Richard Njouom</name><affiliation wicri:level="1"><nlm:affiliation>Virology Department, Pasteur Center of Cameroun, Yaoundé, Cameroon.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Virology Department, Pasteur Center of Cameroun, Yaoundé</wicri:regionArea><wicri:noRegion>Yaoundé</wicri:noRegion></affiliation></author><author><name sortKey="Lissock, Frederic" sort="Lissock, Frederic" uniqKey="Lissock F" first="Frédéric" last="Lissock">Frédéric Lissock</name><affiliation wicri:level="1"><nlm:affiliation>Virology Department, Pasteur Center of Cameroun, Yaoundé, Cameroon.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Virology Department, Pasteur Center of Cameroun, Yaoundé</wicri:regionArea><wicri:noRegion>Yaoundé</wicri:noRegion></affiliation></author><author><name sortKey="Tamko Mella, Gishlaine Flore" sort="Tamko Mella, Gishlaine Flore" uniqKey="Tamko Mella G" first="Gishlaine Flore" last="Tamko-Mella">Gishlaine Flore Tamko-Mella</name><affiliation wicri:level="1"><nlm:affiliation>Virology Department, Pasteur Center of Cameroun, Yaoundé, Cameroon.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Virology Department, Pasteur Center of Cameroun, Yaoundé</wicri:regionArea><wicri:noRegion>Yaoundé</wicri:noRegion></affiliation></author><author><name sortKey="Rallier, Sandrine" sort="Rallier, Sandrine" uniqKey="Rallier S" first="Sandrine" last="Rallier">Sandrine Rallier</name><affiliation wicri:level="3"><nlm:affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Créteil</settlement></placeName></affiliation></author><author><name sortKey="Poiteau, Lila" sort="Poiteau, Lila" uniqKey="Poiteau L" first="Lila" last="Poiteau">Lila Poiteau</name><affiliation wicri:level="3"><nlm:affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Créteil</settlement></placeName></affiliation></author><author><name sortKey="Soulier, Alexandre" sort="Soulier, Alexandre" uniqKey="Soulier A" first="Alexandre" last="Soulier">Alexandre Soulier</name><affiliation wicri:level="3"><nlm:affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Créteil</settlement></placeName></affiliation></author><author><name sortKey="Chevaliez, Stephane" sort="Chevaliez, Stephane" uniqKey="Chevaliez S" first="Stéphane" last="Chevaliez">Stéphane Chevaliez</name><affiliation wicri:level="3"><nlm:affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Créteil</settlement></placeName></affiliation></author><author><name sortKey="Vernet, Guy" sort="Vernet, Guy" uniqKey="Vernet G" first="Guy" last="Vernet">Guy Vernet</name><affiliation wicri:level="1"><nlm:affiliation>Virology Department, Pasteur Center of Cameroun, Yaoundé, Cameroon.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Virology Department, Pasteur Center of Cameroun, Yaoundé</wicri:regionArea><wicri:noRegion>Yaoundé</wicri:noRegion></affiliation></author><author><name sortKey="Rouveau, Nicolas" sort="Rouveau, Nicolas" uniqKey="Rouveau N" first="Nicolas" last="Rouveau">Nicolas Rouveau</name><affiliation wicri:level="3"><nlm:affiliation>"Research in Resource-Limited Settings" Department, ANRS, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>"Research in Resource-Limited Settings" Department, ANRS, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Pawlotsky, Jean Michel" sort="Pawlotsky, Jean Michel" uniqKey="Pawlotsky J" first="Jean-Michel" last="Pawlotsky">Jean-Michel Pawlotsky</name><affiliation wicri:level="3"><nlm:affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Créteil</settlement></placeName></affiliation></author><author><name sortKey="Girard, Pierre Marie" sort="Girard, Pierre Marie" uniqKey="Girard P" first="Pierre-Marie" last="Girard">Pierre-Marie Girard</name><affiliation wicri:level="3"><nlm:affiliation>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Lacombe, Karine" sort="Lacombe, Karine" uniqKey="Lacombe K" first="Karine" last="Lacombe">Karine Lacombe</name><affiliation wicri:level="3"><nlm:affiliation>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><series><title level="j">Journal of the International AIDS Society</title><idno type="eISSN">1758-2652</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Cameroon (epidemiology)</term><term>Coinfection</term><term>Cross-Sectional Studies</term><term>Female</term><term>HIV Infections (complications)</term><term>HIV Infections (epidemiology)</term><term>Hepatitis B (complications)</term><term>Hepatitis C Antibodies (blood)</term><term>Hepatitis C Antigens (blood)</term><term>Hepatitis C, Chronic (complications)</term><term>Hepatitis C, Chronic (diagnosis)</term><term>Hepatitis C, Chronic (epidemiology)</term><term>Hepatitis C, Chronic (virology)</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>ROC Curve</term><term>Sensitivity and Specificity</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anticorps de l'hépatite C (sang)</term><term>Antigènes de l'hépatite C (sang)</term><term>Cameroun (épidémiologie)</term><term>Co-infection</term><term>Courbe ROC</term><term>Femelle</term><term>Humains</term><term>Hépatite B ()</term><term>Hépatite C chronique ()</term><term>Hépatite C chronique (diagnostic)</term><term>Hépatite C chronique (virologie)</term><term>Hépatite C chronique (épidémiologie)</term><term>Infections à VIH ()</term><term>Infections à VIH (épidémiologie)</term><term>Mâle</term><term>Sensibilité et spécificité</term><term>Sujet âgé</term><term>Études transversales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Hepatitis C Antibodies</term><term>Hepatitis C Antigens</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Infections</term><term>Hepatitis B</term><term>Hepatitis C, Chronic</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Hepatitis C, Chronic</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Hépatite C chronique</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cameroon</term><term>HIV Infections</term><term>Hepatitis C, Chronic</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps de l'hépatite C</term><term>Antigènes de l'hépatite C</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Hépatite C chronique</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Hepatitis C, Chronic</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Cameroun</term><term>Hépatite C chronique</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Coinfection</term><term>Cross-Sectional Studies</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>ROC Curve</term><term>Sensitivity and Specificity</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Co-infection</term><term>Courbe ROC</term><term>Femelle</term><term>Humains</term><term>Hépatite B</term><term>Hépatite C chronique</term><term>Infections à VIH</term><term>Mâle</term><term>Sensibilité et spécificité</term><term>Sujet âgé</term><term>Études transversales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The diagnostic procedure for chronic hepatitis C infection (CHC) usually combines anti-HCV antibody (HCV-Ab) and HCV-RNA measurement. Quantifying HCV core antigen (cAg) as a one-step procedure could shorten the diagnostic process. We aimed to assess the performance of cAg quantification in diagnosing CHC and how it is influenced by concomitant HIV or HBV infections.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28530032</PMID><DateCreated><Year>2017</Year><Month>05</Month><Day>22</Day></DateCreated><DateCompleted><Year>2017</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2017</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-2652</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>05</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of the International AIDS Society</Title><ISOAbbreviation>J Int AIDS Soc</ISOAbbreviation></Journal><ArticleTitle>HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study.</ArticleTitle><Pagination><MedlinePgn>21446</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7448/IAS.20.1.21446</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The diagnostic procedure for chronic hepatitis C infection (CHC) usually combines anti-HCV antibody (HCV-Ab) and HCV-RNA measurement. Quantifying HCV core antigen (cAg) as a one-step procedure could shorten the diagnostic process. We aimed to assess the performance of cAg quantification in diagnosing CHC and how it is influenced by concomitant HIV or HBV infections.</AbstractText><AbstractText Label="METHODS">The cAg was quantified by an automated assay (Abbott Diagnostics) in 465 HCV-Ab negative serum samples and 544 HCV-RNA positive serum samples (n = 1009) collected in patients from the Pasteur Center in Cameroon, some of whom were infected by HBV or HIV. Its performance was evaluated in comparison to the gold standard (ELISA or PCR) by estimating its sensitivity (Se) and specificity (Sp), and by comparing the area under ROC (AUROC) curves in each patient population: HCV mono-infected, HCV-HBV and HIV-HCV co-infected.</AbstractText><AbstractText Label="RESULTS">Among the 465 HCV-Ab negative patients, 51 and 79 were HIV- and HBV-infected, respectively, whereas among the 544 patients with CHC, 27 and 28 were HIV- and HBV-infected, respectively. The Spearman ρ correlation coefficient between cAg and HCV-RNA was 0.75 (p < 0.00001). The assay had a sensitivity of 95.7% (95% CI: 93.2-97.5) and a specificity of 99.7% (95% CI: 98.1-10) in diagnosing CHC, corresponding to an AUROC of 0.99 (95% CI: 0.98-1.0). Being HIV- or HBV-infected did not impact the performance of cAg (Se = 96.4%, Sp = 96.2% and AUROC = 0.98 (95% CI: 0.95-1.0) in the HBV group, Se = 100%, Sp = 88.2% and AUROC = 0.99 (95% CI: 0.97-1.0) in the HIV group, p between AUROC = 0.69).</AbstractText><AbstractText Label="CONCLUSIONS">The cAg quantification displayed a high specificity and sensitivity for the diagnosis of CHC in Cameroon, and its performance was not significantly modified by a concomitant HIV or HBV infection. In the context of CHC elimination on a global scale, using cAg quantification as a screening tool to directly identify CHC could be a reliable tool in a "test and treat" strategy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duchesne</LastName><ForeName>Léa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Njouom</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Virology Department, Pasteur Center of Cameroun, Yaoundé, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lissock</LastName><ForeName>Frédéric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Virology Department, Pasteur Center of Cameroun, Yaoundé, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamko-Mella</LastName><ForeName>Gishlaine Flore</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Virology Department, Pasteur Center of Cameroun, Yaoundé, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rallier</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poiteau</LastName><ForeName>Lila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soulier</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chevaliez</LastName><ForeName>Stéphane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vernet</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Virology Department, Pasteur Center of Cameroun, Yaoundé, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouveau</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>"Research in Resource-Limited Settings" Department, ANRS, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pawlotsky</LastName><ForeName>Jean-Michel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girard</LastName><ForeName>Pierre-Marie</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service des maladies infectieuses et tropicales, Hôpital Saint-Antoine, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacombe</LastName><ForeName>Karine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, UPMC Univ Paris 06, Inserm, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service des maladies infectieuses et tropicales, Hôpital Saint-Antoine, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Studies</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Int AIDS Soc</MedlineTA><NlmUniqueID>101478566</NlmUniqueID><ISSNLinking>1758-2652</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018937">Hepatitis C Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018936">Hepatitis C Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2016 Sep 6;165(5):345-55</RefSource><PMID Version="1">27322622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Intervirology. 2015;58(2):73-9</RefSource><PMID Version="1">25677196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2016 Apr 1;213(7):1087-95</RefSource><PMID Version="1">26333945</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2016 Sep 10;388(10049):1081-1088</RefSource><PMID Version="1">27394647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2016 Apr 1;213(7):1055-6</RefSource><PMID Version="1">26333943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Virol. 2013 Nov;85(11):1913-8</RefSource><PMID Version="1">23897630</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2002 Jul;36(1):211-8</RefSource><PMID Version="1">12085367</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transfusion. 2000 Oct;40(10):1198-202</RefSource><PMID Version="1">11061855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Virol. 2013 Nov;58(3):535-40</RefSource><PMID Version="1">24041472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepat Mon. 2013 May 30;13(6):e9147</RefSource><PMID Version="1">24032048</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2015 Jan 15;60(2):263-6</RefSource><PMID Version="1">25301216</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Viral Hepat. 2016 Apr;23 (4):244-55</RefSource><PMID Version="1">26477881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Viral Hepat. 2014 Nov;21(11):769-79</RefSource><PMID Version="1">24251818</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Virol. 2014 Sep;61(1):145-8</RefSource><PMID Version="1">24973282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2010 Oct 30;376(9751):1441-2</RefSource><PMID Version="1">20951421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Gastroenterol. 2015 Apr;49(4):e31-40</RefSource><PMID Version="1">24457946</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Virol. 2011 Aug;51(4):264-9</RefSource><PMID Version="1">21621454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin HIV AIDS. 2015 Sep;10(5):369-73</RefSource><PMID Version="1">26185920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Infect Dis. 2014 Nov 05;14:577</RefSource><PMID Version="1">25371245</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Virol. 2005 Jun;76(2):208-14</RefSource><PMID Version="1">15834878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Virol. 2009 Nov;46(3):210-5</RefSource><PMID Version="1">19766055</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Virol. 2007 Feb;38(2):96-100</RefSource><PMID Version="1">17185031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1998 Oct 2;282(5386):103-7</RefSource><PMID Version="1">9756471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Infect Dis. 2014 Apr 23;14:222</RefSource><PMID Version="1">24758157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vox Sang. 2000;78(2):80-5</RefSource><PMID Version="1">10765142</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):193-4</RefSource><PMID Version="1">25708046</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antivir Ther. 2016 Apr 26;:null</RefSource><PMID Version="1">27115431</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(8):e42002</RefSource><PMID Version="1">22870274</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 2007 Aug;45(8):2426-33</RefSource><PMID Version="1">17537941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol Methods. 2015 Mar;213:147-50</RefSource><PMID Version="1">25528203</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Virol. 2015 May;66:15-8</RefSource><PMID Version="1">25866329</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vox Sang. 2001 Jan;80(1):19-23</RefSource><PMID Version="1">11339063</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2014 Nov;61(1 Suppl):S45-57</RefSource><PMID Version="1">25086286</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Glob Health. 2015 Apr;3(4):e195</RefSource><PMID Version="1">25794673</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002163" MajorTopicYN="N">Cameroon</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018937" MajorTopicYN="N">Hepatitis C Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018936" MajorTopicYN="N">Hepatitis C Antigens</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019698" MajorTopicYN="N">Hepatitis C, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">HCV core antigen</Keyword><Keyword MajorTopicYN="Y">HIV</Keyword><Keyword MajorTopicYN="Y">Sub-Saharan Africa</Keyword><Keyword MajorTopicYN="Y">chronic hepatitis C</Keyword><Keyword MajorTopicYN="Y">co-infection</Keyword><Keyword MajorTopicYN="Y">diagnosis</Keyword><Keyword MajorTopicYN="Y">hepatitis B virus</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28530032</ArticleId><ArticleId IdType="doi">10.7448/IAS.20.1.21446</ArticleId><ArticleId IdType="pmc">PMC5515056</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Cameroun</li><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Créteil</li><li>Paris</li></settlement></list><tree><country name="France"><region name="Île-de-France"><name sortKey="Duchesne, Lea" sort="Duchesne, Lea" uniqKey="Duchesne L" first="Léa" last="Duchesne">Léa Duchesne</name></region><name sortKey="Chevaliez, Stephane" sort="Chevaliez, Stephane" uniqKey="Chevaliez S" first="Stéphane" last="Chevaliez">Stéphane Chevaliez</name><name sortKey="Girard, Pierre Marie" sort="Girard, Pierre Marie" uniqKey="Girard P" first="Pierre-Marie" last="Girard">Pierre-Marie Girard</name><name sortKey="Lacombe, Karine" sort="Lacombe, Karine" uniqKey="Lacombe K" first="Karine" last="Lacombe">Karine Lacombe</name><name sortKey="Pawlotsky, Jean Michel" sort="Pawlotsky, Jean Michel" uniqKey="Pawlotsky J" first="Jean-Michel" last="Pawlotsky">Jean-Michel Pawlotsky</name><name sortKey="Poiteau, Lila" sort="Poiteau, Lila" uniqKey="Poiteau L" first="Lila" last="Poiteau">Lila Poiteau</name><name sortKey="Rallier, Sandrine" sort="Rallier, Sandrine" uniqKey="Rallier S" first="Sandrine" last="Rallier">Sandrine Rallier</name><name sortKey="Rouveau, Nicolas" sort="Rouveau, Nicolas" uniqKey="Rouveau N" first="Nicolas" last="Rouveau">Nicolas Rouveau</name><name sortKey="Soulier, Alexandre" sort="Soulier, Alexandre" uniqKey="Soulier A" first="Alexandre" last="Soulier">Alexandre Soulier</name></country><country name="Cameroun"><noRegion><name sortKey="Njouom, Richard" sort="Njouom, Richard" uniqKey="Njouom R" first="Richard" last="Njouom">Richard Njouom</name></noRegion><name sortKey="Lissock, Frederic" sort="Lissock, Frederic" uniqKey="Lissock F" first="Frédéric" last="Lissock">Frédéric Lissock</name><name sortKey="Tamko Mella, Gishlaine Flore" sort="Tamko Mella, Gishlaine Flore" uniqKey="Tamko Mella G" first="Gishlaine Flore" last="Tamko-Mella">Gishlaine Flore Tamko-Mella</name><name sortKey="Vernet, Guy" sort="Vernet, Guy" uniqKey="Vernet G" first="Guy" last="Vernet">Guy Vernet</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004191 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004191 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:28530032
|texte= HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:28530032" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |